Hudson Bay Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,561
Closed -$2.39M 1230
2025
Q2
$2.39M Sell
8,561
-24,965
-74% -$7.07M 0.01% 748
2025
Q1
$10.4M Buy
+33,526
New +$9.9M 0.03% 390
2024
Q3
Sell
-10,000
Closed -$3.12M 846
2024
Q2
$3.12M Sell
10,000
-104,400
-91% -$30.7M 0.01% 467
2024
Q1
$32.5M Buy
114,400
+54,400
+91% +$15.9M 0.18% 80
2023
Q4
$17.3M Buy
+60,000
New +$16.3M 0.11% 114
2023
Q3
Sell
-173,000
Closed -$38.4M 787
2023
Q2
$38.4M Buy
173,000
+168,000
+3,360% +$39M 0.28% 83
2023
Q1
$1.21M Sell
5,000
-202,900
-98% -$49.8M 0.01% 571
2022
Q4
$54.6M Buy
+207,900
New +$55.7M 0.56% 40
2021
Q4
Sell
-10,800
Closed -$2.3M 1083
2021
Q3
$2.3M Buy
+10,800
New +$2.49M 0.03% 599
2019
Q1
Sell
-2,500
Closed -$487K 685
2018
Q4
$487K Buy
+2,500
New +$488K 0.01% 696
2018
Q2
Sell
-16,800
Closed -$2.97M 772
2018
Q1
$2.86M Buy
+16,800
New +$3.08M 0.06% 361

Other funds holding AMGN

Hudson Bay Capital Management's AMGN Position: Q3 2025 in Review

Hudson Bay Capital Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 8,561 shares — an estimated $2.39M sold.

Hudson Bay Capital Management first reported a position in AMGN in Q1 2018 and held it in 11 quarters. The position peaked at $54.6M in Q4 2022. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Hudson Bay Capital Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 8,561 Amgen shares in Q3 2025, an estimated $2.39M.
  • Hudson Bay Capital Management first reported a position in Amgen in Q1 2018 and held it in 11 quarters.
  • Hudson Bay Capital Management's Amgen position peaked at $54.6M in Q4 2022.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Hudson Bay Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.